Retrace could be, investors scared of further downgrade. An Analyst cautioned about that. However, I placed an order @ lower than current price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025